NCT04861064View on ClinicalTrials.gov

Weekly Sirolimus Therapy

PHASE2RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 18, 2022

Primary Completion Date

February 28, 2026

Study Completion Date

June 30, 2026

Conditions
Venous MalformationLymphatic Malformation
Interventions
DRUG

Sirolimus

Participants will get Sirolimus (1.5-2 2mg/m2) weekly for 6 months.

Trial Locations (1)

29403

RECRUITING

Medical University of South Carolina, Charleston

All Listed Sponsors
lead

Medical University of South Carolina

OTHER